CD3 Receptor Agonists [MoA] - N0000175618

Pharmacologic Code	N0000175618
Pharmacologic Name	CD3 Receptor Agonists
Pharmacologic Uses	bispecific CD19-directed CD3 T-cell engager bispecific gp100 peptide-HLA-directed CD3 T cell engager
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class CD3 Receptor Agonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	80446-401	Kimmtrak	Non-Proprietary Name: Tebentafusp	Injection, Solution, Concentrate	Intravenous	Immunocore Commercial Llc	ACTIVE